Tri-Supply
Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007.
It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product.
It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.
Financial Data
-
31st Dec 16 Source: CRO
- €98.3 million turnover
-
€44,242
profit
-
31st Dec 15 Source: CRO
- €172.6 million turnover
-
-€82
profit - 0 employees
- 5 more years available »
Ranking
By Turnover
(€98.3 million)- 473rd in Top Companies
- 51st in Pharma
-
- €98.3 million
Employees
- David Cadogan Director
Latest News
- 11:34am Ryanair to begin flying from Bosnia and Herzegovina
- 7:54am US sanctions puts future of Aughinish plant in doubt
- 7:38am UBS boosts first-quarter earnings thanks to strong investment bank
- 7:24am Housebuilding in Ireland still among the lowest in Europe
- 6:51am Walmart close to $12bn deal for India’s Flipkart